Iteos Therapeutics Stock Options
| ITOS Stock | USD 8.15 0.25 3.16% |
Iteos Therapeutics' latest option contracts expiring on January 17th 2025 are carrying combined implied volatility of 0.76. The Iteos Therapeutics option chain provides detailed quote and price information for the current Iteos Therapeutics option contracts. It shows all of Iteos Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Iteos Therapeutics Maximum Pain Price Across 2025-01-17 Option Contracts
Max pain occurs when Iteos Therapeutics' market makers reach a net positive position across all Iteos Therapeutics' options at a strike price where option holders stand to lose the most money. By contrast, Iteos Therapeutics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Iteos Therapeutics
Analyzing Iteos Therapeutics' in-the-money options over time can help investors to take a profitable long position in Iteos Therapeutics regardless of its overall volatility. This is especially true when Iteos Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Iteos Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Iteos Therapeutics' stock while costing only a fraction of its price.
Iteos Current Options Market Mood
Iteos Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Iteos Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Iteos Therapeutics' options investors are not very successful. Iteos Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Iteos contract
Base on the Rule 16, the options market is currently suggesting that Iteos Therapeutics will have an average daily up or down price movement of about 0.0475% per day over the life of the 2025-01-17 option contract. With Iteos Therapeutics trading at USD 8.15, that is roughly USD 0.003871. If you think that the market is fully incorporating Iteos Therapeutics' daily price movement you should consider buying Iteos Therapeutics options at the current volatility level of 0.76%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Iteos |
Purchasing Iteos Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Iteos calls. Remember, the seller must deliver Iteos Therapeutics stock to the call owner when a call is exercised.
Iteos Therapeutics Option Chain
When Iteos Therapeutics' strike price is surpassing the current stock price, the option contract against Iteos Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Iteos Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Iteos. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Iteos. It also shows strike prices and maturity days for a Iteos Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ITOS250117C00009000 | 0 | 9.0 | 7.2 - 11.9 | 7.2 | |
Call | ITOS250117C00010000 | 0 | 10.0 | 6.7 - 11.5 | 6.7 | |
Call | ITOS250117C00011000 | 0 | 11.0 | 6.0 - 10.7 | 6.0 | |
Call | ITOS250117C00012000 | 0 | 12.0 | 5.2 - 10.0 | 5.2 | |
Call | ITOS250117C00013000 | 0 | 13.0 | 4.6 - 9.4 | 4.6 | |
Call | ITOS250117C00014000 | 0 | 14.0 | 4.3 - 9.0 | 4.3 | |
Call | ITOS250117C00015000 | 0 | 15.0 | 3.9 - 8.5 | 3.9 | |
Call | ITOS250117C00016000 | 0 | 16.0 | 3.3 - 8.0 | 3.3 | |
Call | ITOS250117C00017000 | 0 | 17.0 | 2.8 - 7.5 | 2.8 | |
Call | ITOS250117C00018000 | 0 | 18.0 | 2.5 - 7.0 | 2.5 | |
Put | ITOS250117P00009000 | 0 | 9.0 | 0.0 - 5.0 | 5.0 | |
Put | ITOS250117P00010000 | 0 | 10.0 | 0.0 - 5.0 | 5.0 | |
Put | ITOS250117P00011000 | 0 | 11.0 | 0.1 - 4.9 | 0.1 | |
Put | ITOS250117P00012000 | 0 | 12.0 | 0.1 - 5.0 | 0.1 | |
Put | ITOS250117P00013000 | 0 | 13.0 | 0.2 - 5.0 | 0.2 | |
Put | ITOS250117P00014000 | 0 | 14.0 | 0.2 - 5.0 | 0.2 | |
Put | ITOS250117P00015000 | 0 | 15.0 | 0.2 - 5.0 | 0.2 | |
Put | ITOS250117P00016000 | 0 | 16.0 | 0.7 - 5.4 | 0.7 | |
Put | ITOS250117P00017000 | 0 | 17.0 | 1.1 - 5.7 | 1.1 | |
Put | ITOS250117P00018000 | 0 | 18.0 | 1.9 - 6.5 | 1.9 |
Iteos Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Iteos Total Stockholder Equity
Total Stockholder Equity |
|
Iteos Therapeutics Corporate Management
| Matthew Gall | Chief Officer | Profile | |
| Matthew MBA | Chief Officer | Profile | |
| Ryan Baker | Head Relations | Profile | |
| Joanne MD | Chief Officer | Profile | |
| Adi Osovsky | Executive Legal | Profile |
Additional Tools for Iteos Stock Analysis
When running Iteos Therapeutics' price analysis, check to measure Iteos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iteos Therapeutics is operating at the current time. Most of Iteos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Iteos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iteos Therapeutics' price. Additionally, you may evaluate how the addition of Iteos Therapeutics to your portfolios can decrease your overall portfolio volatility.